Diabetes drug Avandia banned in Europe, restricted in US

Published September 27, 2010

Diabetes drug Avandia banned in Europe, restricted in US
The diabetes drug Avandia will no longer be available to patients in Europe and will be restricted in the US over fears it increases the risk of heart attack and strokes, regulators said Thursday.
Read more on AFP via Yahoo! Philippines News

Vical shares sink as company handles drug failure
(AP:INDIANAPOLIS) Shares of drug developer Vical Inc. continued to slide Friday afternoon, as the company priced a stock offering two days after a drug it discovered failed in a late-stage clinical trial.
Read more on INO News

Results From Argos Therapeutics’ Arcelis™ Immunotherapy Phase 2 Study For Treatment Of Renal Cell Carcinoma (RCC …
Argos Therapeutics announced that results from its Arcelis™ immunotherapy Phase 2 study for the treatment of renal cell carcinoma (RCC) have been accepted for a poster presentation at the Ninth International Kidney Cancer Symposium on Oct. 1-2 in Chicago. The study is an open-label Phase 2 trial that enrolled 25 patients with newly diagnosed metastatic clear cell RCC. Post-nephrectomy, subjects …
Read more on Medical News Today